Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
暂无分享,去创建一个
M. Andrews | K. Liu | G. McMurray | J. Blagg | C. Allerton | L. Watson | D. Ellis | Edelweiss Evrard | Vivienne Sanderson | R. Ward | Michael J. Ralph | Martin P. Green
[1] Tokio Yamaguchi,et al. Characterization of intracavernous pressure increase induced by Ym348, a novel 5-HT2C receptor agonist, in anesthetized rats. , 2006, The Journal of urology.
[2] A. Ramage. The role of central 5‐hydroxytryptamine (5‐HT, serotonin) receptors in the control of micturition , 2006, British journal of pharmacology.
[3] C. Sánchez,et al. Different roles of 5-HT2A and 5-HT2C receptors in regulation of female rat paced mating behaviour , 2004, Behavioural Brain Research.
[4] R. Millard,et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four‐continent randomized clinical trial , 2004, BJU international.
[5] J. Leysen,et al. 5-HT2 receptors. , 2004, Current drug targets. CNS and neurological disorders.
[6] M. J. Bishop,et al. New 5-HT2C receptor agonists , 2003 .
[7] K. Thor. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence. , 2003, Urology.
[8] D. Harmer,et al. 5‐HT2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro , 2002, British journal of pharmacology.
[9] J. Brioni,et al. Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function. , 2001, Life sciences.
[10] B. Roth,et al. Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications , 2000, Circulation.
[11] J. C. Winter,et al. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects ofm-chlorophenylpiperazine , 1995, Psychopharmacology.
[12] P P Humphrey,et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.
[13] F. Bochner,et al. Potentiation of ADP‐induced aggregation in human platelet‐rich plasma by 5‐hydroxytryptamine and adrenaline , 1992, British journal of pharmacology.
[14] B. Ames,et al. Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.
[15] B. Ames,et al. A SIMPLE METHOD FOR DETECTING ENVIRONMENTAL CARCINOGENS AS MUTAGENS * , 1976, Annals of the New York Academy of Sciences.
[16] B. Ames,et al. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Kuraishi. 4,5-Substituted pyridazines. III. Oxidation and solvolysis of 4-methyl-3,6-dichloropyridazine. , 1957, Pharmaceutical bulletin.
[18] E. Amstutz,et al. THE PREPARATION OF SOME DIALKYL PYRIDAZINES , 1955 .